»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
½ÉÀåÀÌ½Ä Ä¡·á ½ÃÀåÀº 2024-2029³â 1¾ï 2,970¸¸ ´Þ·¯ Áõ°¡Çϰí, ¿¹Ãø ±â°£ µ¿¾È 3%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¼¼°èÀÇ ½ÉÀåÀÌ½Ä Ä¡·á ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ ´ë»óÀ¸·Î ÇÑ º¥´õ ºÐ¼® µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
ÇöÀçÀÇ ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ ¹× ¼ºÀå¿äÀÎ, Àüü ½ÃÀå ȯ°æ¿¡ ´ëÇÑ ÃֽŠºÐ¼®À» Á¦°øÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀº ½ÉÇ÷°ü Áúȯ ¹× ½ÉºÎÀü À¯º´·ü Áõ°¡, ´Ù¾çÇÑ Á¦ÇüÀÇ ¾à¹° °¡¿ë¼º, ½ÉÀåÀÌ½Ä ½Ã ¸é¿ª¾ïÁ¦Á¦¿¡ ´ëÇÑ ÀÇÁ¸µµ Áõ°¡¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§
±âÁØ ¿¬µµ
2025³â
Á¾·á ¿¬µµ
2029³â
¿¹Ãø ±â°£
2025-2029³â
¼ºÀå ¸ð¸àÅÒ
°¡¼Ó
Àü³â ´ëºñ 2025³â
2.8%
CAGR
3%
Áõ°¡¾×
1¾ï 2,970¸¸ ´Þ·¯
ÀÌ Á¶»ç´Â ¾÷°è ÁÖ¿ä Âü°¡ÀÚÀÇ ÀǰßÀ» Æ÷ÇÔÇÏ¿© 1Â÷ ¹× 2Â÷ Á¤º¸¸¦ °´°üÀûÀ¸·Î °áÇÕÇÏ¿© ¼öÇàµÇ¾ú½À´Ï´Ù. ÀÌ º¸°í¼¿¡´Â ÁÖ¿ä ±â¾÷ ºÐ¼®, Á¾ÇÕÀûÀÎ ½ÃÀå ±Ô¸ð µ¥ÀÌÅÍ, Áö¿ªº° ºÐ¼®¿¡ µû¸¥ ºÎ¹®, °ø±Þ¾÷ü ÇöȲÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. º¸°í¼¿¡´Â °ú°Å µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅͰ¡ ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼´Â ÇâÈÄ ¸î ³âµ¿¾È ½ÉÀåÀÌ½Ä Ä¡·á ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß Çϳª·Î ½ÉÀåÀÌ½Ä °ü·Ã ±¹Á¦ Çù·Â °ü°èÀÇ È®´ë¸¦ ²Å°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÉÀåÀ̽ÄÀ» À§ÇÑ ±â¼úÀÇ ÃâÇö, ½ÉÀåÀ̽Ŀ¡ ´ëÇÑ Àνİú Á¢±Ù¼º Çâ»óÀº ½ÃÀåÀÇ Å« ¼ö¿ä·Î À̾îÁú °ÍÀÔ´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå TechnavioÀÇ ºÐ¼®
°¡°Ý, ¼ö¸íÁÖ±â, °í°´ ±¸ÀÔ ¹Ù½ºÄÏ, äÅà ºñÀ², ±¸ÀÔ ±âÁØ ºÐ¼®
ÀÎDzÀÇ Á߿伺°ú Â÷º°È ¿äÀÎ
È¥¶õ ¿äÀÎ
¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
Á¦3Àå ½ÃÀå ±¸µµ
½ÃÀå »ýŰè
½ÃÀå Æ¯Â¡
¹ë·ùüÀÎ ºÐ¼®
Á¦4Àå ½ÃÀå ±Ô¸ð
½ÃÀåÀÇ Á¤ÀÇ
½ÃÀå ºÎ¹® ºÐ¼®
½ÃÀå ±Ô¸ð 2024
½ÃÀå Àü¸Á 2024-2029
Á¦5Àå ½ÃÀå ±Ô¸ð ½ÇÀû
¼¼°èÀÇ ½ÉÀåÀÌ½Ä Ä¡·á ½ÃÀå(2019-2023³â)
¾àÁ¦ Ŭ·¡½ºº° ºÎ¹® ºÐ¼®(2019-2023³â)
À¯Åë ä³Îº° ºÎ¹® ºÐ¼®(2019-2023³â)
À¯Çüº° ºÎ¹® ºÐ¼®(2019-2023³â)
ÀûÀÀÁõº° ºÎ¹® ºÐ¼®(2019-2023³â)
Áö¿ªº° ºÎ¹® ºÐ¼®(2019-2023³â)
±¹°¡º° ºÎ¹® ºÐ¼®(2019-2023³â)
Á¦6Àå Á¤¼º ºÐ¼®
AIÀÇ ¿µÇâ : ¼¼°èÀÇ ½ÉÀåÀÌ½Ä Ä¡·á ½ÃÀå
Á¦7Àå Five Forces ºÐ¼®
Five Forces ¿ä¾à
¹ÙÀ̾îÀÇ ±³¼··Â
°ø±Þ ±â¾÷ÀÇ ±³¼··Â
½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
´ëüǰÀÇ À§Çù
°æÀï À§Çù
½ÃÀå ÇöȲ
Á¦8Àå ½ÃÀå ¼¼ºÐÈ : ¾àÁ¦ Ŭ·¡½ºº°
½ÃÀå ºÎ¹®
ºñ±³ : ¾àÁ¦ Ŭ·¡½ºº°
¸é¿ª¾ïÁ¦Á¦ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
Ç×°¨¿°Á¦ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ÁøÅëÁ¦ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
±âŸ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÃÀå ±âȸ : ¾àÁ¦ Ŭ·¡½ºº°
Á¦9Àå ½ÃÀå ¼¼ºÐÈ : À¯Åë ä³Îº°
½ÃÀå ºÎ¹®
ºñ±³ : À¯Åë ä³Îº°
º´¿ø ¾à±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¼Ò¸Å ¾à±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¿Â¶óÀÎ ¾à±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÃÀå ±âȸ : À¯Åë ä³Îº°
Á¦10Àå ½ÃÀå ¼¼ºÐÈ : À¯Çüº°
½ÃÀå ºÎ¹®
ºñ±³ : À¯Çüº°
ÁÂ½É½Ç º¸Á¶ ÀåÄ¡(LVAD) : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÉÀåÀÌ½Ä : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
À̽ÄÇü ½ÉÀå Á¦¼¼µ¿±â(ICD) : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¿¡Å©¸ð(ECMO) : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÃÀå ±âȸ : À¯Çüº°
Á¦11Àå ½ÃÀå ¼¼ºÐÈ : ÀûÀÀÁõº°
½ÃÀå ºÎ¹®
ºñ±³ : ÀûÀÀÁõº°
ÇãÇ÷¼º ½ÉÁúȯ(IHD) : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
È®ÀåÇü ½É±ÙÁõ(DCM) : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ÆÇ¸·Áõ(VHD) : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ºñ´ëÇü ½É±ÙÁõ(HCM) : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÃÀå ±âȸ : ÀûÀÀÁõº°
Á¦12Àå °í°´ »óȲ
Á¦13Àå Áö¿ªº° »óȲ
Áö¿ªº° ¼¼ºÐÈ
Áö¿ªº° ºñ±³
ºÏ¹Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
À¯·´ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¾Æ½Ã¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¼¼°è ±âŸ Áö¿ª : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¹Ì±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
µ¶ÀÏ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ij³ª´Ù : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ÇÁ¶û½º : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ÀϺ» : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¿µ±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
Àεµ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
Áß±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
Çѱ¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ÀÌÅ»¸®¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÃÀå ±âȸ : Áö¿ª »óȲº°
Á¦14Àå ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ±âȸ ¹× ¼ºÀå ¾ïÁ¦¿äÀÎ
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
½ÃÀå ±âȸ¿Í ¼ºÀå ¾ïÁ¦¿äÀÎ
Á¦15Àå °æÀï ±¸µµ
°³¿ä
°æÀï ±¸µµ
È¥¶õ »óȲ
¾÷°è ¸®½ºÅ©
Á¦16Àå °æÀï ºÐ¼®
±â¾÷ °³¿ä
±â¾÷ ¼øÀ§ Áö¼ö
±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×
AbbVie Inc.
Astellas Pharma Inc.
Biocon Ltd.
Dr Reddys Laboratories Ltd.
F. Hoffmann La Roche Ltd.
GlaxoSmithKline Plc
Glenmark Pharmaceuticals Ltd.
Intas Pharmaceuticals Ltd.
LEO Pharma AS
Lupin Ltd.
Novartis AG
Panacea Biotec Ltd.
Pfizer Inc.
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Á¦17Àå ºÎ·Ï
LSH
The heart transplantation therapeutics market is forecasted to grow by USD 129.7 million during 2024-2029, accelerating at a CAGR of 3% during the forecast period. The report on the heart transplantation therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of cardiovascular diseases and heart failures, availability of drugs in multiple dosage forms, and high dependency on immunosuppressants for heart transplantation.
Market Scope
Base Year 2025
End Year 2029
Series Year 2025-2029
Growth Momentum Accelerate
YOY 2025 2.8%
CAGR 3%
Incremental Value $129.7 mn
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's heart transplantation therapeutics market is segmented as below:
By Drug Class
Immunosuppressants
Anti-infectives
Analgesics
Others
By Distribution Channel
Hospital pharmacies
Retail pharmacies
Online pharmacies
By Type
Left ventricular assist device (LVAD)
Heart transplantation
Implantable cardiac defibrillator (ICD)
Extracorporeal membrane oxygenation (ECMO)
By Indication
Ischemic heart disease (IHD)
Dilated cardiomyopathy (DCM)
Valvular heart disease (VHD)
Hypertrophic cardiomyopathy (HCM)
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)
This study identifies the growing international collaborations for heart transplantation as one of the prime reasons driving the heart transplantation therapeutics market growth during the next few years. Also, advent of techniques for heart transplantation and growing awareness and accessibility regarding heart transplantation will lead to sizable demand in the market.
The report on the heart transplantation therapeutics market covers the following areas:
Heart Transplantation Therapeutics Market sizing
Heart Transplantation Therapeutics Market forecast
Heart Transplantation Therapeutics Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading heart transplantation therapeutics market vendors that include AbbVie Inc., Astellas Pharma Inc., Biocon Ltd., DR Reddys Laboratories Ltd., Endo International PLC, F. Hoffmann La Roche Ltd., GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Jubilant Pharmova Ltd., LEO Pharma AS, Lupin Ltd., McKesson Corp., Novartis AG, Panacea Biotec Ltd., Pfizer Inc., RPG Enterprises, Strides Pharma Science Ltd., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.. Also, the heart transplantation therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Drug Class
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by Indication
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Heart Transplantation Therapeutics Market 2019 - 2023
Historic Market Size - Data Table on Global Heart Transplantation Therapeutics Market 2019 - 2023 ($ million)
5.2 Drug Class segment analysis 2019 - 2023
Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
5.3 Distribution Channel segment analysis 2019 - 2023
Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
5.4 Type segment analysis 2019 - 2023
Historic Market Size - Type Segment 2019 - 2023 ($ million)
5.5 Indication segment analysis 2019 - 2023
Historic Market Size - Indication Segment 2019 - 2023 ($ million)
5.6 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.7 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 Impact of AI in global heart transplantation therapeutics market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Drug Class
8.1 Market segments
Chart on Drug Class - Market share 2024-2029 (%)
Data Table on Drug Class - Market share 2024-2029 (%)
8.2 Comparison by Drug Class
Chart on Comparison by Drug Class
Data Table on Comparison by Drug Class
8.3 Immunosuppressants - Market size and forecast 2024-2029
Chart on Immunosuppressants - Market size and forecast 2024-2029 ($ million)
Data Table on Immunosuppressants - Market size and forecast 2024-2029 ($ million)
Chart on Immunosuppressants - Year-over-year growth 2024-2029 (%)
Data Table on Immunosuppressants - Year-over-year growth 2024-2029 (%)
8.4 Anti-infectives - Market size and forecast 2024-2029
Chart on Anti-infectives - Market size and forecast 2024-2029 ($ million)
Data Table on Anti-infectives - Market size and forecast 2024-2029 ($ million)
Chart on Anti-infectives - Year-over-year growth 2024-2029 (%)
Data Table on Anti-infectives - Year-over-year growth 2024-2029 (%)
8.5 Analgesics - Market size and forecast 2024-2029
Chart on Analgesics - Market size and forecast 2024-2029 ($ million)
Data Table on Analgesics - Market size and forecast 2024-2029 ($ million)
Chart on Analgesics - Year-over-year growth 2024-2029 (%)
Data Table on Analgesics - Year-over-year growth 2024-2029 (%)
8.6 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
8.7 Market opportunity by Drug Class
Market opportunity by Drug Class ($ million)
Data Table on Market opportunity by Drug Class ($ million)
9 Market Segmentation by Distribution Channel
9.1 Market segments
Chart on Distribution Channel - Market share 2024-2029 (%)
Data Table on Distribution Channel - Market share 2024-2029 (%)
9.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
9.3 Hospital pharmacies - Market size and forecast 2024-2029
Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
9.4 Retail pharmacies - Market size and forecast 2024-2029
Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
9.5 Online pharmacies - Market size and forecast 2024-2029
Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)
10 Market Segmentation by Type
10.1 Market segments
Chart on Type - Market share 2024-2029 (%)
Data Table on Type - Market share 2024-2029 (%)
10.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
10.3 Left ventricular assist device (LVAD) - Market size and forecast 2024-2029
Chart on Left ventricular assist device (LVAD) - Market size and forecast 2024-2029 ($ million)
Data Table on Left ventricular assist device (LVAD) - Market size and forecast 2024-2029 ($ million)
Chart on Left ventricular assist device (LVAD) - Year-over-year growth 2024-2029 (%)
Data Table on Left ventricular assist device (LVAD) - Year-over-year growth 2024-2029 (%)
10.4 Heart transplantation - Market size and forecast 2024-2029
Chart on Heart transplantation - Market size and forecast 2024-2029 ($ million)
Data Table on Heart transplantation - Market size and forecast 2024-2029 ($ million)
Chart on Heart transplantation - Year-over-year growth 2024-2029 (%)
Data Table on Heart transplantation - Year-over-year growth 2024-2029 (%)
10.5 Implantable cardiac defibrillator (ICD) - Market size and forecast 2024-2029
Chart on Implantable cardiac defibrillator (ICD) - Market size and forecast 2024-2029 ($ million)
Data Table on Implantable cardiac defibrillator (ICD) - Market size and forecast 2024-2029 ($ million)
Chart on Implantable cardiac defibrillator (ICD) - Year-over-year growth 2024-2029 (%)
Data Table on Implantable cardiac defibrillator (ICD) - Year-over-year growth 2024-2029 (%)
10.6 Extracorporeal membrane oxygenation (ECMO) - Market size and forecast 2024-2029
Chart on Extracorporeal membrane oxygenation (ECMO) - Market size and forecast 2024-2029 ($ million)
Data Table on Extracorporeal membrane oxygenation (ECMO) - Market size and forecast 2024-2029 ($ million)
Chart on Extracorporeal membrane oxygenation (ECMO) - Year-over-year growth 2024-2029 (%)
Data Table on Extracorporeal membrane oxygenation (ECMO) - Year-over-year growth 2024-2029 (%)
10.7 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
11 Market Segmentation by Indication
11.1 Market segments
Chart on Indication - Market share 2024-2029 (%)
Data Table on Indication - Market share 2024-2029 (%)
11.2 Comparison by Indication
Chart on Comparison by Indication
Data Table on Comparison by Indication
11.3 Ischemic heart disease (IHD) - Market size and forecast 2024-2029
Chart on Ischemic heart disease (IHD) - Market size and forecast 2024-2029 ($ million)
Data Table on Ischemic heart disease (IHD) - Market size and forecast 2024-2029 ($ million)
Chart on Ischemic heart disease (IHD) - Year-over-year growth 2024-2029 (%)
Data Table on Ischemic heart disease (IHD) - Year-over-year growth 2024-2029 (%)
11.4 Dilated cardiomyopathy (DCM) - Market size and forecast 2024-2029
Chart on Dilated cardiomyopathy (DCM) - Market size and forecast 2024-2029 ($ million)
Data Table on Dilated cardiomyopathy (DCM) - Market size and forecast 2024-2029 ($ million)
Chart on Dilated cardiomyopathy (DCM) - Year-over-year growth 2024-2029 (%)
Data Table on Dilated cardiomyopathy (DCM) - Year-over-year growth 2024-2029 (%)
11.5 Valvular heart disease (VHD) - Market size and forecast 2024-2029
Chart on Valvular heart disease (VHD) - Market size and forecast 2024-2029 ($ million)
Data Table on Valvular heart disease (VHD) - Market size and forecast 2024-2029 ($ million)
Chart on Valvular heart disease (VHD) - Year-over-year growth 2024-2029 (%)
Data Table on Valvular heart disease (VHD) - Year-over-year growth 2024-2029 (%)
11.6 Hypertrophic cardiomyopathy (HCM) - Market size and forecast 2024-2029
Chart on Hypertrophic cardiomyopathy (HCM) - Market size and forecast 2024-2029 ($ million)
Data Table on Hypertrophic cardiomyopathy (HCM) - Market size and forecast 2024-2029 ($ million)
Chart on Hypertrophic cardiomyopathy (HCM) - Year-over-year growth 2024-2029 (%)
Data Table on Hypertrophic cardiomyopathy (HCM) - Year-over-year growth 2024-2029 (%)
11.7 Market opportunity by Indication
Market opportunity by Indication ($ million)
Data Table on Market opportunity by Indication ($ million)
12 Customer Landscape
12.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape
13.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
13.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
13.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
13.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
13.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
13.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
13.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
13.8 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
13.9 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
13.10 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
13.11 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
13.12 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
13.13 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
13.14 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
13.15 South Korea - Market size and forecast 2024-2029
Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Chart on South Korea - Year-over-year growth 2024-2029 (%)
Data Table on South Korea - Year-over-year growth 2024-2029 (%)
13.16 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ million)
Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
13.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
14 Drivers, Challenges, and Opportunity/Restraints
14.1 Market drivers
14.2 Market challenges
14.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
14.4 Market opportunities/restraints
15 Competitive Landscape
15.1 Overview
15.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
15.3 Landscape disruption
Overview on factors of disruption
15.4 Industry risks
Impact of key risks on business
16 Competitive Analysis
16.1 Companies profiled
16.2 Company ranking index
16.3 Market positioning of companies
Matrix on companies position and classification
16.4 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
SWOT
16.5 Astellas Pharma Inc.
Astellas Pharma Inc. - Overview
Astellas Pharma Inc. - Product / Service
Astellas Pharma Inc. - Key offerings
SWOT
16.6 Biocon Ltd.
Biocon Ltd. - Overview
Biocon Ltd. - Business segments
Biocon Ltd. - Key offerings
Biocon Ltd. - Segment focus
SWOT
16.7 Dr Reddys Laboratories Ltd.
Dr Reddys Laboratories Ltd. - Overview
Dr Reddys Laboratories Ltd. - Business segments
Dr Reddys Laboratories Ltd. - Key news
Dr Reddys Laboratories Ltd. - Key offerings
Dr Reddys Laboratories Ltd. - Segment focus
SWOT
16.8 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
SWOT
16.9 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
SWOT
16.10 Glenmark Pharmaceuticals Ltd.
Glenmark Pharmaceuticals Ltd. - Overview
Glenmark Pharmaceuticals Ltd. - Product / Service
Glenmark Pharmaceuticals Ltd. - Key offerings
SWOT
16.11 Intas Pharmaceuticals Ltd.
Intas Pharmaceuticals Ltd. - Overview
Intas Pharmaceuticals Ltd. - Product / Service
Intas Pharmaceuticals Ltd. - Key offerings
SWOT
16.12 LEO Pharma AS
LEO Pharma AS - Overview
LEO Pharma AS - Product / Service
LEO Pharma AS - Key offerings
SWOT
16.13 Lupin Ltd.
Lupin Ltd. - Overview
Lupin Ltd. - Business segments
Lupin Ltd. - Key news
Lupin Ltd. - Key offerings
Lupin Ltd. - Segment focus
SWOT
16.14 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
16.15 Panacea Biotec Ltd.
Panacea Biotec Ltd. - Overview
Panacea Biotec Ltd. - Product / Service
Panacea Biotec Ltd. - Key news
Panacea Biotec Ltd. - Key offerings
SWOT
16.16 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
16.17 Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. - Overview
Sun Pharmaceutical Industries Ltd. - Product / Service
Sun Pharmaceutical Industries Ltd. - Key news
Sun Pharmaceutical Industries Ltd. - Key offerings
SWOT
16.18 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
SWOT
17 Appendix
17.1 Scope of the report
17.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
17.3 Currency conversion rates for US$
Currency conversion rates for US$
17.4 Research methodology
17.5 Data procurement
17.6 Data validation
17.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
17.8 Data synthesis
17.9 360 degree market analysis
360 degree market analysis
17.10 List of abbreviations